OBJECTIVEdHemoglobin A 1c (HbA 1c ) has been widely used as a clinically important assessment tool for outcome analyses related to glycemic control. However, because of special conditions in dialysis patients, including the uremic milieu, there is no HbA 1c blood glucose (BG) equation specific for patients on dialysis. In this study, we sought to develop HbA 1c -BG equation models for hemodialysis patients.
is a reliable substitute for mean BG and, except for analytic variation, the only important factor determining HbA 1c is the preceding mean BG.
Glycation rate is determined by temperature, pH, hemoglobin (Hb) concentration, BG concentration, and length of exposure to glucose (3) . Because the Hb concentration and pH of dialysis patients can be significantly abnormal, the correlation between HbA 1c and AG levels in dialysis patients is considered different from that of normal patients. Furthermore, shortened erythrocyte life span and accelerated erythropoesis because of routine use of erythropoietin could affect HbA 1c levels in dialysis patients. HbA 1c was found to underestimate glucose measurements in diabetic patients on dialysis compared with glycated albumin (4) (5) (6) . Unfortunately, there has been no HbA 1c -AG equation specific for hemodialysis (HD) patients, despite the increasing number of diabetic patients on dialysis. In this study, we sought to develop HbA 1c -AG equation models for HD patients.
RESEARCH DESIGN AND METHODS

Database creation
The data were obtained from DaVita, the second largest dialysis care provider in the United States, with ;500 dialysis centers and 40,000 patients across the country. The creation of the national DaVita dialysis patient cohort has been described previously (7) (8) (9) (10) (11) (12) . A 60-month prevalent cohort (July 2001-June 2006) of DaVita maintenance HD patients was studied. Demographic data and details of medical history were collected, with information on age, gender, race, and presence of diabetes. The study conformed to Declaration of Helsinki and Good Clinical Practice Guidelines. In addition to linear models, quadratic, root, log, and exponential regression models also were applied to estimate the relationship between averaged HbA 1c and BG. Bootstrapping method also was used to estimate AG and corresponding HbA 1c for more reliable estimates. One thousand resampling procedures with replacement were selected to approximate the sampling distribution of statistics of interest. R 2 and root mean square error were used to compare the correlations between the simple and multivariate regression models. After identifying the best models, we applied them to gender-based and race-based categories to compare the accuracy of the models in each subgroup. The DCCT and the ADAG formulas were used as control formulas.
Laboratory measures
RESULTS
Equation model creation
Baseline characteristics are shown in Table 1. The mean age was 63 6 12 years, which was slightly higher in Asians (66 6 11 years) than in African Americans (62 6 12 years). Most patients were non-Hispanic white (33%), African American (34%), and Hispanic (21%), with relatively few Asian and other races, including Pacific Islander and Native Americans. The mean dialysis vintage was 2.9 6 2.5 years. Eighty percent of patients in this study had type 2 diabetes mellitus. Most characteristics were similar in males and females.
The relationship between the average HbA 1c and the AG (n = 11,986) is shown in Fig. 1 and Table 2 . The scatter plot suggests that there is a linear relationship between HbA 1c and BG, which is the same as the relationship previously reported in nondialysis populations (1,2). Rohlfing et al. (1) also reported that afternoon and evening BG showed higher correlations with HbA 1c than did the morning values. Our analysis also showed that the relationship between HbA 1c and BG among patients in the afternoon or evening shift (R 2 = 0.494) was better than during the morning (R 2 = 0.477) (see Supplementary Fig. 1 ). Next, we compared several equation models with and without adjustment for confounding factors. As shown in Table 2 , the equation improved if Alb was added (R 2 = 0.468-0.483) to the model. The R 2 gradually improved after adding age or race variables, or both, although the degree of improvement was not large. We could not find any improvement after adding gender Table 1dBaseline patients' characteristics (n = 11,986)
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Blood glucose estimation
Next, we compared AG and estimated BG using our models and previously reported equations (ADAG and DCCT models established for nondialysis populations).
Compared with previous equations (ADAG and DCCT models established for nondialysis populations; adjusted R 2 = 0.468), all our models showed better correlation (adjusted R 2 = 0.483, 0.486, and 0.491) (Fig. 2) in HD patients. In addition, the glucose levels estimated by the DCCT and ADAG models were similar to those of our models if patients had Alb level of 4.0 mg/dL and if HbA 1c was .9.0%. However, the estimated glucose levels by the previous models were lower if patients had lower Alb levels or lower HbA 1c levels (Table 3) .
Utility of the model in race-and gender-based subgroups Because our models suggested that race also was an independent covariate in the HbA 1c -AG equation model, we checked correlations separately in each race group. Moreover, because the number of Asians was relatively small (n = 402; 3% of the study population), it was essential to check the utility of the equation in this group. As shown in Table 4 , the adjusted R 2 between the AG and the estimated BG using our model 3 and model 8 in nonHispanic whites were 0.470 and 0.479 in males and 0.466 and 0.472 in females. There was a higher correlation in African Americans (adjusted R 2 = 0.530 and 0.538 in males and 0.531 and 0.538 in females) and Hispanics (adjusted R 2 = 0.498 and 0.511 in males and 0.478 and 0.488 in females) compared with nonHispanic whites, but a lower association among Asians (adjusted R 2 = 0.385 and 0.387 in males and 0.400 and 0.414 in females). These data suggested that this model may work especially well in African American and Hispanic populations.
CONCLUSIONSdIn this large-scale cohort of 11,986 diabetic HD patients (69,764 samples), we reported new HbA 1c and BG equation models that are at least as good or better than previous equations. To the best of our knowledge, this is the first model for HD patients showing better correlation than the previous standard formulas that were developed for nondialysis patients. Interestingly, the slope of the glucose variable in our model was almost identical to that in the ADAG model. HbA 1c has been considered to underestimate glucose measurements in diabetic patients on HD compared with glycated albumin (4-6).
Using the ADAG and DCCT model, the estimated glucose levels tended to be lower than the AG (Table 3) .
Although previous observational studies have yielded inconsistent results regarding the association between glycemic control and outcomes in diabetic HD patients, our recent study suggested that after adjusting for potential confounders, higher HbA 1c values were associated with higher death risk in patients on maintenance HD (13, 14) . Therefore, HbA 1c is considered an important clinical marker for glycemic control. There have been several other measurements that represent glycemic levels for patients with chronic kidney disease, such as glycated albumin (15) Rambod et al. (17) reported that low HbA 1c levels could be considered a surrogate marker of protein-energy wasting, which is a well-known predictor of mortality in dialysis patients. Similarly, we previously reported that Alb levels were associated with HbA 1c levels (14) . As shown in Table 3 , the estimated glucose levels in this study were higher by ;20 mg/dL if Alb levels decreased from 4.0 to 3.0 g/dL. Patients on dialysis have a higher prevalence of hypercatabolism compared with the general population, which could affect Alb levels (18) . Our results supported a simple linear relationship between mean glucose and HbA 1c levels in a clinically relevant range of glycemia that was reported by Nathan et al. (2), but it also revealed the importance of taking into account the Alb level in the equation between HbA 1c and AG for dialysis patients, especially because Alb values in dialysis patients are usually lower than they are in the general population. In addition, our analysis revealed that careful interpretation of HbA 1c is needed if patients had malnutrition and anemia, known as MIA syndrome. In these patients, equation models including Alb and Hb (model 4 or complex model) may be useful to estimate their average glucose levels.
It was reported that postprandial BG was associated with survival in HD patients (19) and there was no difference for mean amplitude of glycemic excursion between the day on and day off HD by an analysis of continuous glucose monitoring (20) . In addition, as shown in the Supplementary Fig. 1 , our data showed that afternoon and evening BG measurements, not fasting BG, had better correlation with their HbA 1c levels, which was consistent with the results for patients without end-stage renal disease reported by Rohlfing et al. (1) . These findings may imply that initiation of HD may be best after BG measurement. If patients start dialysis with fasting, then postprandial glucose measurement should be added. Also if subjects use maintained antidiabetes agents, BG measurement during HD should be added, because glucose levels decrease with initiation of HD when using these agents (20) .
There are several limitations in this study. First, our data were not based on continuous daily BG monitoring. However, the large number of random BG samples available to us and the bootstrapping technique may minimize this problem. Furthermore, our equations obtained by bootstrapping showed similar results with the estimation obtained by using timeaveraged values, suggesting robustness of our models. Second, the proportion of the care.diabetesjournals.org DIABETES CARE, VOLUME 36, APRIL 2013 925
Asian population was small in our data set. Therefore, our model might not be representative enough for the HbA 1c -AG association in Asians. In fact, compared with other races, the correlations in Asians were relatively weak. Third, our population consisted of patients with relatively early dialysis vintage. The association between HbA 1c and glucose may be different in patients with longer vintage, because uremia and routine use of erythropoietin could affect HbA 1c . Finally, our models may not represent patients on peritoneal dialysis (PD). Because they are exposed to a greater glucose charge present in dialysate solution, their glucose behavior may be different from that of patients on HD. In addition, lack of information on PD prescription would add more residual confounding. A large database consisting of PD patients is needed to develop HbA 1c -AG equation models for patients on PD.
In conclusion, there was a predictable relationship between HbA 1c and AG in HD patients. Our new models for HD patients showed better correlations between HbA 1c and AG compared with previous models. The model including Alb is better-suited for HD patients because of the lower Alb levels in this population. Similar to reporting serum creatinine with the calculated glomerular filtration rate, HbA 1c levels should provide patients and health care providers with a more useful index of day-to-day BG levels. 
